Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImpact Health Regulatory News (IHR)

Share Price Information for Impact Health (IHR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 85.20
Bid: 85.00
Ask: 85.30
Change: 0.10 (0.12%)
Spread: 0.30 (0.353%)
Open: 86.50
High: 86.50
Low: 84.80
Prev. Close: 85.10
IHR Live PriceLast checked at -
Impact Healthcare REIT is an Investment Trust

To seek to provide Shareholders with an attractive return, principally in the form of quarterly income distributions and with the potential for capital and income growth through exposure to a diversified portfolio of Healthcare Real Estate Assets.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Two Care Homes and New Tenant

22 Aug 2022 07:00

RNS Number : 6568W
Impact Healthcare REIT PLC
22 August 2022
 

The information contained in this announcement is restricted and is not for publication, release or distribution in the United States of America, any member state of the European Economic Area (other than the Republic of Ireland or the Netherlands), Canada, Australia, Japan or the Republic of South Africa.

 

22 August 2022

Impact Healthcare REIT plc

("Impact" or the "Company" or, together with its subsidiaries, the "Group")

ACQUIRES TWO CARE HOMES FOR £14 MILLION AND WELCOMES A NEW TENANT

The board of directors of Impact Healthcare REIT plc (ticker: IHR), the real estate investment trust which gives investors exposure to a diversified portfolio of UK healthcare real estate assets, in particular care homes, is pleased to announce that the Group has recently exchanged contracts to acquire two care homes in Kent for £14.0 million plus acquisition costs. These acquisitions are with a new tenant, Belmont Healthcare ("Belmont"), the Group's 14th tenant.

 

One home is a purpose-built, 120-bedroom property split over four units, each with 30 beds. It has strong operational cashflows and is located on a generous site, which has significant potential for future value-enhancing asset management and development opportunities. Following completion, we intend to invest further in the property to reconfigure the existing layout of each unit, reducing the number of bedrooms in each from 30 to 20. This will enable Belmont to deliver elements of an innovative 'household' model of care for residents with dementia, developed in the Netherlands, which has proven beneficial to residents. These works will be undertaken on a phased basis to enable occupancy to be maintained. There is further potential for complementary, healthcare-related development on the site, which we intend to pursue once the existing units have been reconfigured.

 

The second transaction is the sale and leaseback of a home currently owned and operated by Belmont. It has 48 bedrooms with en suite bathrooms. The home has been recently refurbished and extended. The acquisition of this home includes a potential deferred payment of up to £550k, subject to its continued strong trading performance. The deferred payment, if it becomes payable, will result in increased rental payments, ensuring that the effective purchase yield of this asset remains materially unchanged.

 

Both properties are well located and have an excellent reputation for quality care with 'Good' CQC inspection ratings.

 

Once completed, these transactions are expected to deliver the following benefits to the Group:

· enable the Group to deploy an initial £14.0 million of capital, plus transaction costs, followed by additional asset management and development opportunities;

· the initial annual rent has been agreed at £890,000, reflecting an accretive gross initial yield of 6.36%;

· will add two care homes comprising 168 beds to the Group's portfolio, which will then total 136 care homes and 7,484 beds1 (at 31 December 2021: 124 homes and 6,720 beds);

· EPC ratings of B on both homes; and

· introduce a new tenant, the Group's 14th. Further acquisitions with Belmont are under consideration.

 

These acquisitions will be leased on Impact's standard green leases, with fixed terms of 25 years and annual upward-only rent reviews linked to the Retail Price Index ("RPI"), with a floor of 2% p.a. and a cap of 4% p.a., with commitments to a minimum annual expenditure by the tenant on the maintenance of the care homes.

 

Completion is subject to re-registration with the Care Quality Commission.

 

The Company's investment manager, Impact Health Partners LLP, is in developed legal discussions on several other acquisition opportunities and expects to make further announcements in the near future.

 

FOR FURTHER INFORMATION, PLEASE CONTACT:

Impact Health Partners LLP

Via Maitland/AMO

Mahesh Patel

Andrew Cowley

David Yaldron

Jefferies International Limited

+44 20 7029 8000

Tom Yeadon

tyeadon@jefferies.com

Neil Winward

nwinward@jefferies.com

Winterflood Securities Limited

+44 20 3100 0000

Neil Langford

neil.langford@winterflood.com

Joe Winkley

joe.winkley@winterflood.com

Maitland/AMO (Communications adviser)

+44 7747 113 930

James Benjamin

impacthealth-maitland@maitland.co.uk

Alistair de Kare-silver

 

The Company's LEI is 213800AX3FHPMJL4IJ53.

 

Further information on Impact Healthcare REIT is available at www.impactreit.uk.

 

NOTES:

Impact Healthcare REIT plc acquires, renovates, extends and redevelops high quality healthcare real estate assets in the UK and lets these assets on long-term full repairing and insuring leases to high-quality established healthcare operators which offer good quality care, under leases which provide the Company with attractive levels of rent cover.

 

The Company aims to provide shareholders with an attractive sustainable return, principally in the form of quarterly income distributions and with the potential for capital and income growth, through exposure to a diversified and resilient portfolio of UK healthcare real estate assets, in particular care homes for the elderly.

 

The Company has a progressive dividend policy with a target to grow its annual aggregate dividend in line with the inflation-linked rental uplifts received by the Group under the terms of the rent review provisions contained in the Group's leases in the prior financial year.

 

On this basis, the Company is targeting a dividend for the year to 31 December 2022 to increase by 2.0% to 6.54 pence per share2.

 

The Group's Ordinary Shares were admitted to trading on the main market of the London Stock Exchange, premium segment, on 8 February 2019. The Company is a constituent of the FTSE EPRA/NAREIT index.

 

Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.

 

1 Including forward funded assets and portfolios invested in via a loan

2 This is a target only and not a profit forecast. There can be no assurance that the target will be met and it should not be taken as an indicator of the Company's expected or actual results.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQUKOURUAUWAAR
Date   Source Headline
1st Feb 20187:00 amRNSDividend Declaration
11th Jan 20187:00 amRNSAcquisition
20th Dec 201710:34 amRNSHolding(s) in Company
16th Nov 201711:56 amRNSHolding(s) in Company
10th Nov 20174:44 pmRNSHolding(s) in Company
8th Nov 20177:00 amRNSSuccessful fund raising of £32.6 million
6th Nov 20172:58 pmRNSResult of General Meeting
1st Nov 20177:00 amRNSDividend Declaration
16th Oct 20177:00 amRNSNet Asset Value and Proposed Placing
22nd Sep 20177:00 amRNSINTERIM RESULTS FOR THE PERIOD TO 30 JUNE 2017
31st Jul 20175:43 pmRNSTrading Update and Dividend Declaration
31st Jul 20177:00 amRNSTrading Update
30th Jun 20177:00 amRNSStatement re Change in accounting reference date
30th Jun 20177:00 amRNSStatement re Appointment of Non-Executive Director
29th Jun 20177:00 amRNSAcquisition of Saffron Court
17th May 20177:00 amRNSNotification of Home State
4th May 20177:00 amRNSAcquisition of Seed Portfolio
10th Mar 20173:13 pmRNSHolding(s) in Company
9th Mar 201712:10 pmRNSDirector/PDMR Shareholding
9th Mar 201712:10 pmRNSDirector/PDMR Shareholding
9th Mar 201712:09 pmRNSDirector/PDMR Shareholding
9th Mar 201712:09 pmRNSDirector/PDMR Shareholding
7th Mar 20178:01 amRNSFirst day of dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.